Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)

OBJECTIVE: Most investigations of pharmacotherapy for treating Alzheimer's disease focus on patients with mild‐to‐moderate symptoms, with little evidence to guide clinical decisions when symptoms become severe. We examined whether continuing donepezil, or commencing memantine, is cost‐effective...

Full description

Saved in:
Bibliographic Details
Published in:Int J Geriatr Psychiatry
Main Authors: Knapp, Martin, King, Derek, Romeo, Renée, Adams, Jessica, Baldwin, Ashley, Ballard, Clive, Banerjee, Sube, Barber, Robert, Bentham, Peter, Brown, Richard G, Burns, Alistair, Dening, Tom, Findlay, David, Holmes, Clive, Johnson, Tony, Jones, Robert, Katona, Cornelius, Lindesay, James, Macharouthu, Ajay, McKeith, Ian, McShane, Rupert, O'Brien, John T, Phillips, Patrick P J, Sheehan, Bart, Howard, Robert
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2016
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5724694/
https://ncbi.nlm.nih.gov/pubmed/27739182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/gps.4583
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items